Kiadis Pharma B.V., a clinical stage biopharmaceutical company developing treatments for blood cancers, announced today that it has raised EUR 10 million in an equity financing round.
http://www.biospace.com/news_story.aspx?StoryID=280242&full=1
http://www.biospace.com/news_story.aspx?StoryID=280242&full=1
No comments:
Post a Comment